Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Onconetix (ONCO) Non Operating Income (2023 - 2025)

Historic Non Operating Income for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to -$6.7 million.

  • Onconetix's Non Operating Income fell 44239.77% to -$6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.3 million, marking a year-over-year decrease of 8441.2%. This contributed to the annual value of -$3.2 million for FY2024, which is 13401.79% down from last year.
  • Per Onconetix's latest filing, its Non Operating Income stood at -$6.7 million for Q3 2025, which was down 44239.77% from -$437024.0 recorded in Q2 2025.
  • In the past 5 years, Onconetix's Non Operating Income registered a high of $4.0 million during Q1 2025, and its lowest value of -$6.7 million during Q3 2025.
  • For the 3-year period, Onconetix's Non Operating Income averaged around -$705607.4, with its median value being -$437024.0 (2025).
  • In the last 5 years, Onconetix's Non Operating Income plummeted by 989250.77% in 2024 and then soared by 264503.28% in 2025.
  • Onconetix's Non Operating Income (Quarter) stood at -$314812.0 in 2023, then plummeted by 284.5% to -$1.2 million in 2024, then tumbled by 454.7% to -$6.7 million in 2025.
  • Its last three reported values are -$6.7 million in Q3 2025, -$437024.0 for Q2 2025, and $4.0 million during Q1 2025.